Anew Medical, Inc.
NASDAQ Global MarketCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Joseph Sinkule
- Full Time Employees
- 1
- Sector
- Healthcare
- Industry
- Biotechnology
- Address
- 13576 Walnut Street Omaha NE United States of America 68144
- Website
- anewmeds.com
- Similar Companies
- Business
- Anew Medical, Inc. stands as a biopharmaceutical enterprise, dedicated to advancing transformative treatments for neurological and age-related conditions, alongside specialized diagnostic tools. The company focuses on developing cell and gene therapies designed to address the progression of pathologies linked to aging, encompassing symptoms of dementia, Alzheimer's disease, amyotrophic lateral sclerosis (ALS), and Parkinson's disease. Its core efforts center on a proprietary Klotho gene therapy program, aiming to restore and augment levels of the secreted Klotho protein, often recognized for its role in longevity and brain function. This innovative approach extends to developing diagnostics for measuring Klotho levels in blood, supporting both clinical trials and broader health screening. Anew Medical maintains a significant research collaboration with Japan's Okinawa Research Center for Longevity Science, focusing on the Klotho gene's potential to enhance lifespan and mitigate age-related illnesses. The company initiated trading on Nasdaq under the ticker WENA in June 2024 and achieved debt-free status in August 2024 through the conversion of over $4 million in notes. Anew Medical, Inc. is headquartered in Omaha, Nebraska.
ANEW MEDICAL, Inc. Announces Name Change to Klotho Neurosciences, Inc.
ANEW MEDICAL, Inc. Announces Name Change to Klotho Neurosciences, Inc.
Healthy Longevity is One of Key Development Goals of ANEW's Novel Gene Therapy
Healthy Longevity is One of Key Development Goals of ANEW's Novel Gene Therapy
ANEW MEDICAL, INC. Achieves Debt-Free Status, Boosts Financial Flexibility
ANEW MEDICAL, INC. Achieves Debt-Free Status, Boosts Financial Flexibility
ANEW MEDICAL, INC. Acquires License to Needle-Free Dry Powder Autoinjector from Transfertech Sherbrooke (“TTS”)
ANEW MEDICAL, INC. Acquires License to Needle-Free Dry Powder Autoinjector from Transfertech Sherbrooke (“TTS”)
ANEW MEDICAL, INC. Appoints New CFO
ANEW MEDICAL, INC. Appoints New CFO
ANEW MEDICAL, INC. Strengthens Intellectual Property Protection with U.S. Patent Issuance for Its Secreted RNA Splice Variant of the Human Klotho Gene Used for the Treatment of Neurodegenerative and Age-Related Diseases
ANEW MEDICAL, INC. Strengthens Intellectual Property Protection with U.S. Patent Issuance for Its Secreted RNA Splice Variant of the Human Klotho Gene Used for the Treatment of Neurodegenerative and Age-Related Diseases
ANEW MEDICAL, INC. Pursues Neurological Approach to Treating Weight Loss and Eating Disorders through Melanocortin Receptor Binding Peptides
ANEW MEDICAL, INC. Pursues Neurological Approach to Treating Weight Loss and Eating Disorders through Melanocortin Receptor Binding Peptides
4 Stocks Moving Sharply Before the Market Opens
Why Is Anew Medical (WENA) Stock Up 37% Today?
Why Is Anew Medical (WENA) Stock Up 51% Today?
ANEW MEDICAL to Advance Patented Klotho Gene Therapy for Neurodegenerative Disorder Treatments
ANEW MEDICAL to Advance Patented Klotho Gene Therapy for Neurodegenerative Disorder Treatments
ANEW MEDICAL Forms Strategic Partnership with Japan's Okinawa Research Center for Longevity Science (ORCLS) to Study Klotho Gene